InMed First To Take Cannabinol To Clinical Trials
Marijuana Stocks, Finance, & Investing January 22, 2020 MJ Shareholders 0
InMed First To Take Cannabinol To Clinical Trials " />
In a “bad” year for the emerging cannabis industry, global cannabis sales rose by 48% in 2019. That’s not bad.
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.